المؤلفون: Serebrovskaya EO; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia; Current position: Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Bryushkova EA; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia; Department of Molecular Biology, Lomonosov Moscow State University, Moscow, Russia., Lukyanov DK; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia; Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia., Mushenkova NV; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; Unicorn Capital Partners, 119049, Moscow, Russia., Chudakov DM; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia; Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia; Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Electronic address: chudakovdm@gmail.com., Turchaninova MA; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia.

المصدر: Seminars in immunology [Semin Immunol] 2024 Mar; Vol. 72, pp. 101864. Date of Electronic Publication: 2024 Jan 31.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: England NLM ID: 9009458 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-3618 (Electronic) Linking ISSN: 10445323 NLM ISO Abbreviation: Semin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: B-Lymphocyte Subsets* , Neoplasms*, Humans ; B-Lymphocytes ; Receptors, Antigen, B-Cell ; Tumor Microenvironment

المؤلفون: Bryushkova EA; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia; Department of Molecular Biology, Lomonosov Moscow State University, Moscow, Russia., Mushenkova NV; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; Unicorn Capital Partners, Moscow, Russia., Turchaninova MA; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia., Lukyanov DK; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia; Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia., Chudakov DM; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia; Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia; Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Electronic address: chudakovdm@gmail.com., Serebrovskaya EO; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia; Current position: Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.

المصدر: Seminars in immunology [Semin Immunol] 2024 Mar; Vol. 72, pp. 101874. Date of Electronic Publication: 2024 Mar 19.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: England NLM ID: 9009458 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-3618 (Electronic) Linking ISSN: 10445323 NLM ISO Abbreviation: Semin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes* , Neoplasms*/therapy , Neoplasms*/metabolism, Humans ; Lymphocytes, Tumor-Infiltrating ; B-Lymphocytes ; Immunotherapy ; Tumor Microenvironment

المؤلفون: Bryushkova EA; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia., Skatova VD; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Mutovina ZY; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia., Zagrebneva AI; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia., Fomina DS; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Kruglova TS; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia., Akopyan AA; Pirogov Russian National Research Medical University, Moscow, Russia., Strazhesko ID; Pirogov Russian National Research Medical University, Moscow, Russia., Lukyanov SA; Pirogov Russian National Research Medical University, Moscow, Russia., Tkacheva ON; Pirogov Russian National Research Medical University, Moscow, Russia., Lysenko MA; Pirogov Russian National Research Medical University, Moscow, Russia.; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia., Chudakov DM; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.

المصدر: PloS one [PLoS One] 2022 Aug 24; Vol. 17 (8), pp. e0273340. Date of Electronic Publication: 2022 Aug 24 (Print Publication: 2022).

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19 Drug Treatment*, Adult ; Anti-Inflammatory Agents/therapeutic use ; Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; Azetidines ; Humans ; Purines ; Pyrazoles ; SARS-CoV-2 ; Sulfonamides ; Treatment Outcome

المؤلفون: Goncharov MM; Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russian Federation.; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation., Bryushkova EA; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.; Department of Molecular Biology, Moscow State University, Moscow, Russian Federation.; Pirogov Russian National Research Medical University, Moscow, Russian Federation., Sharaev NI; Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russian Federation., Skatova VD; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.; Pirogov Russian National Research Medical University, Moscow, Russian Federation., Baryshnikova AM; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.; Pirogov Russian National Research Medical University, Moscow, Russian Federation., Sharonov GV; Pirogov Russian National Research Medical University, Moscow, Russian Federation.; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russian Federation., Karnaukhov V; Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russian Federation.; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation., Vakhitova MT; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.; Department of Molecular Biology, Moscow State University, Moscow, Russian Federation., Samoylenko IV; Oncodermatology Department, NN Blokhin Russian Cancer Research Center, Moscow, Russian Federation., Demidov LV; Oncodermatology Department, NN Blokhin Russian Cancer Research Center, Moscow, Russian Federation., Lukyanov S; Pirogov Russian National Research Medical University, Moscow, Russian Federation., Chudakov DM; Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russian Federation.; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.; Pirogov Russian National Research Medical University, Moscow, Russian Federation., Serebrovskaya EO; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.; Pirogov Russian National Research Medical University, Moscow, Russian Federation.; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russian Federation.

المصدر: ELife [Elife] 2022 Apr 04; Vol. 11. Date of Electronic Publication: 2022 Apr 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes* , Neoplasms*/metabolism , Neoplasms*/therapy, Antigens, Neoplasm/metabolism ; Humans ; Lymphocytes, Tumor-Infiltrating ; Receptors, Antigen, T-Cell/metabolism

المؤلفون: Dyugay IA; Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia., Lukyanov DK; Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia., Turchaninova MA; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Serebrovskaya EO; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Bryushkova EA; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.; Molecular Biology Department, Lomonosov Moscow State University, Moscow, Russia., Zaretsky AR; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Khalmurzaev O; Department of Urology, Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow, Russia., Matveev VB; Department of Urology, Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow, Russia., Shugay M; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Shelyakin PV; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Chudakov DM; Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.

المصدر: Cancer immunology research [Cancer Immunol Res] 2022 Mar 01; Vol. 10 (3), pp. 343-353.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Carcinoma, Transitional Cell*/drug therapy , Urinary Bladder Neoplasms*, B7-H1 Antigen ; Female ; Humans ; Immunoglobulin A ; Immunoglobulin G/metabolism ; Immunotherapy/methods ; Lymphocytes, Tumor-Infiltrating ; Male ; Selection Bias

المؤلفون: Bryushkova EA; Department of Molecular Biology, Lomonosov Moscow State University, Lenin Hills 1/12, Moscow, 119991, Russian Federation., Gandalipov ER; Laboratory of Solution Chemistry of Advanced Materials and Technologies, ITMO University, Lomonosova 9, St. Petersburg, 197101, Russian Federation., Nuzhina JV; Laboratory of Solution Chemistry of Advanced Materials and Technologies, ITMO University, Lomonosova 9, St. Petersburg, 197101, Russian Federation.

المصدر: Beilstein journal of organic chemistry [Beilstein J Org Chem] 2020 May 27; Vol. 16, pp. 1135-1141. Date of Electronic Publication: 2020 May 27 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Beilstein-Institut Country of Publication: Germany NLM ID: 101250746 Publication Model: eCollection Cited Medium: Print ISSN: 1860-5397 (Print) Linking ISSN: 18605397 NLM ISO Abbreviation: Beilstein J Org Chem Subsets: PubMed not MEDLINE

المؤلفون: Yuzhakova DV; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia., Volchkova LN; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia., Pogorelyy MV; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Department of Molecular Technologies, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Serebrovskaya EO; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Department of Molecular Technologies, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Shagina IA; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Department of Molecular Technologies, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Bryushkova EA; Department of Molecular Technologies, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.; Department of Molecular Biology, Moscow State University, Moscow, Russia., Nakonechnaya TO; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Department of Molecular Technologies, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Izosimova AV; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia., Zavyalova DS; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia., Karabut MM; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia., Izraelson M; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Department of Molecular Technologies, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Samoylenko IV; Oncodermatology Department, N. N. Blokhin Russian Cancer Research Center, Moscow, Russia., Zagainov VE; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.; Volga District Medical Centre Under Federal Medical and Biological Agency, Nizhny Novgorod, Russia., Chudakov DM; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Department of Molecular Technologies, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.; Adaptive Immunity Group, Central European Institute of Technology, Masaryk University, Brno, Czechia.; MiLaboratory LLC, Skolkovo Innovation Centre, Moscow, Russia., Zagaynova EV; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia., Sharonov GV; Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Department of Molecular Technologies, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.

المصدر: Frontiers in oncology [Front Oncol] 2020 May 08; Vol. 10, pp. 512. Date of Electronic Publication: 2020 May 08 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Nedorezova DD; Laboratory of Solution Chemistry of Advanced Materials and Technologies, ITMO University, 9 Lomonosova Str., St. Petersburg, 191002, Russian Federation., Fakhardo AF; Laboratory of Solution Chemistry of Advanced Materials and Technologies, ITMO University, 9 Lomonosova Str., St. Petersburg, 191002, Russian Federation., Nemirich DV; Laboratory of Solution Chemistry of Advanced Materials and Technologies, ITMO University, 9 Lomonosova Str., St. Petersburg, 191002, Russian Federation., Bryushkova EA; Laboratory of Solution Chemistry of Advanced Materials and Technologies, ITMO University, 9 Lomonosova Str., St. Petersburg, 191002, Russian Federation., Kolpashchikov DM; Laboratory of Solution Chemistry of Advanced Materials and Technologies, ITMO University, 9 Lomonosova Str., St. Petersburg, 191002, Russian Federation.; Chemistry Department, University of Central Florida, Orlando, FL, 32816-2366, USA.; Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, 32816, USA.

المصدر: Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2019 Mar 26; Vol. 58 (14), pp. 4654-4658. Date of Electronic Publication: 2019 Feb 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 0370543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-3773 (Electronic) Linking ISSN: 14337851 NLM ISO Abbreviation: Angew Chem Int Ed Engl Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Therapy*, Biomarkers, Tumor/*metabolism , DNA, Neoplasm/*metabolism , Nanostructures/*chemistry , Neoplasms/*therapy , RNA, Messenger/*genetics, Biomarkers, Tumor/chemistry ; DNA, Catalytic/chemistry ; DNA, Catalytic/metabolism ; DNA, Neoplasm/chemistry ; Humans ; Nanotechnology ; Neoplasms/metabolism ; RNA Folding ; RNA, Messenger/metabolism

المؤلفون: Solovev YV; ITMO University, SCAMT laboratory 9, Lomonosova str., Saint Petersburg, 191002, Russian Federation., Prilepskii AY; ITMO University, SCAMT laboratory 9, Lomonosova str., Saint Petersburg, 191002, Russian Federation., Krivoshapkina EF; ITMO University, SCAMT laboratory 9, Lomonosova str., Saint Petersburg, 191002, Russian Federation., Fakhardo AF; ITMO University, SCAMT laboratory 9, Lomonosova str., Saint Petersburg, 191002, Russian Federation., Bryushkova EA; ITMO University, SCAMT laboratory 9, Lomonosova str., Saint Petersburg, 191002, Russian Federation., Kalikina PA; ITMO University, SCAMT laboratory 9, Lomonosova str., Saint Petersburg, 191002, Russian Federation., Koshel EI; ITMO University, SCAMT laboratory 9, Lomonosova str., Saint Petersburg, 191002, Russian Federation., Vinogradov VV; ITMO University, SCAMT laboratory 9, Lomonosova str., Saint Petersburg, 191002, Russian Federation. vinogradov@scamt-itmo.ru.

المصدر: Scientific reports [Sci Rep] 2019 Feb 04; Vol. 9 (1), pp. 1176. Date of Electronic Publication: 2019 Feb 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Metal Nanoparticles* , Phase Transition*, Aluminum Hydroxide/*chemical synthesis , Aluminum Oxide/*chemical synthesis , Drug Carriers/*chemical synthesis, A549 Cells ; Anti-Bacterial Agents/metabolism ; Antineoplastic Agents/metabolism ; Cell Survival/drug effects ; Escherichia coli/drug effects ; HeLa Cells ; Humans ; Hydrogen-Ion Concentration ; Protein Binding ; Proteins/metabolism

المؤلفون: Nikitina AA; ITMO University , St. Petersburg 191002 , Russian Federation., Ulasevich SA; ITMO University , St. Petersburg 191002 , Russian Federation., Kassirov IS; ITMO University , St. Petersburg 191002 , Russian Federation., Bryushkova EA; ITMO University , St. Petersburg 191002 , Russian Federation., Koshel EI; ITMO University , St. Petersburg 191002 , Russian Federation., Skorb EV; ITMO University , St. Petersburg 191002 , Russian Federation.

المصدر: Bioconjugate chemistry [Bioconjug Chem] 2018 Nov 21; Vol. 29 (11), pp. 3793-3799. Date of Electronic Publication: 2018 Nov 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9010319 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4812 (Electronic) Linking ISSN: 10431802 NLM ISO Abbreviation: Bioconjug Chem Subsets: MEDLINE

مواضيع طبية MeSH: Biofilms*, Arabinose/*administration & dosage , Escherichia coli/*physiology , Nanostructures/*chemistry , Polyelectrolytes/*chemistry , Silver/*chemistry , Titanium/*chemistry, Arabinose/metabolism ; Drug Carriers/chemistry ; Fluorescence ; Humans ; Luminescence ; Metal Nanoparticles/chemistry